

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.96808080 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.99859775 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.99859775 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.98681212 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 5.84955429 |
| 6 | viral transcription (GO:0019083) | 5.79645469 |
| 7 | respiratory electron transport chain (GO:0022904) | 5.72475754 |
| 8 | electron transport chain (GO:0022900) | 5.65194238 |
| 9 | translational termination (GO:0006415) | 5.65082852 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 5.58328318 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 5.54249682 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.47564179 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 5.41771993 |
| 14 | proteasome assembly (GO:0043248) | 5.41380523 |
| 15 | protein targeting to ER (GO:0045047) | 5.38728921 |
| 16 | protein complex biogenesis (GO:0070271) | 5.33616754 |
| 17 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 5.21506780 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 5.21506780 |
| 19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.20518842 |
| 20 | rRNA modification (GO:0000154) | 5.18995780 |
| 21 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.16681165 |
| 22 | protein localization to endoplasmic reticulum (GO:0070972) | 5.12420763 |
| 23 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.11889166 |
| 24 | locomotory exploration behavior (GO:0035641) | 5.00277908 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.88334476 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 4.88334476 |
| 27 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.88334476 |
| 28 | translational elongation (GO:0006414) | 4.85389290 |
| 29 | rRNA methylation (GO:0031167) | 4.83344475 |
| 30 | regulation of mitochondrial translation (GO:0070129) | 4.68946411 |
| 31 | maturation of SSU-rRNA (GO:0030490) | 4.61366295 |
| 32 | translation (GO:0006412) | 4.58339537 |
| 33 | cellular modified amino acid catabolic process (GO:0042219) | 4.53058203 |
| 34 | viral life cycle (GO:0019058) | 4.45035963 |
| 35 | ribosomal small subunit assembly (GO:0000028) | 4.44123357 |
| 36 | translational initiation (GO:0006413) | 4.41361263 |
| 37 | coenzyme catabolic process (GO:0009109) | 4.37752703 |
| 38 | protein neddylation (GO:0045116) | 4.34522008 |
| 39 | cellular protein complex disassembly (GO:0043624) | 4.32673377 |
| 40 | C4-dicarboxylate transport (GO:0015740) | 4.31634621 |
| 41 | glutamate secretion (GO:0014047) | 4.23383344 |
| 42 | respiratory chain complex IV assembly (GO:0008535) | 4.20051294 |
| 43 | protein targeting to mitochondrion (GO:0006626) | 4.14885606 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.13322072 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09653926 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09343057 |
| 47 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.07961212 |
| 48 | cytochrome complex assembly (GO:0017004) | 4.03075840 |
| 49 | synaptic vesicle maturation (GO:0016188) | 4.00490722 |
| 50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.98370907 |
| 51 | cellular component biogenesis (GO:0044085) | 3.97222587 |
| 52 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.96345054 |
| 53 | regulation of oxidative phosphorylation (GO:0002082) | 3.85386696 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 3.82144789 |
| 55 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.81588062 |
| 56 | L-amino acid import (GO:0043092) | 3.77532505 |
| 57 | hydrogen ion transmembrane transport (GO:1902600) | 3.74333523 |
| 58 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.73534998 |
| 59 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.72092788 |
| 60 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.71312574 |
| 61 | establishment of protein localization to mitochondrion (GO:0072655) | 3.71263984 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.71031219 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.68791708 |
| 64 | L-phenylalanine metabolic process (GO:0006558) | 3.68791708 |
| 65 | ATP biosynthetic process (GO:0006754) | 3.68107629 |
| 66 | protein localization to mitochondrion (GO:0070585) | 3.67145416 |
| 67 | rRNA processing (GO:0006364) | 3.66894320 |
| 68 | negative regulation of ligase activity (GO:0051352) | 3.66073185 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.66073185 |
| 70 | L-phenylalanine catabolic process (GO:0006559) | 3.63461777 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.63461777 |
| 72 | cullin deneddylation (GO:0010388) | 3.60440589 |
| 73 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.59731992 |
| 74 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.59411100 |
| 75 | protein targeting to membrane (GO:0006612) | 3.58788644 |
| 76 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.55451554 |
| 77 | protein complex disassembly (GO:0043241) | 3.54532725 |
| 78 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.54255130 |
| 79 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.54192684 |
| 80 | rRNA metabolic process (GO:0016072) | 3.52664374 |
| 81 | glutamate metabolic process (GO:0006536) | 3.52630644 |
| 82 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.50545161 |
| 83 | exploration behavior (GO:0035640) | 3.49927677 |
| 84 | pseudouridine synthesis (GO:0001522) | 3.47410247 |
| 85 | lysine catabolic process (GO:0006554) | 3.46206758 |
| 86 | lysine metabolic process (GO:0006553) | 3.46206758 |
| 87 | macromolecular complex disassembly (GO:0032984) | 3.43332131 |
| 88 | transcription from RNA polymerase I promoter (GO:0006360) | 3.43193815 |
| 89 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.43064012 |
| 90 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.42729736 |
| 91 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.42729736 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.39668255 |
| 93 | termination of RNA polymerase I transcription (GO:0006363) | 3.39637945 |
| 94 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35162265 |
| 95 | proton transport (GO:0015992) | 3.33606650 |
| 96 | spliceosomal snRNP assembly (GO:0000387) | 3.33526001 |
| 97 | protein-cofactor linkage (GO:0018065) | 3.32422086 |
| 98 | aspartate family amino acid catabolic process (GO:0009068) | 3.31934054 |
| 99 | mitochondrial transport (GO:0006839) | 3.31463001 |
| 100 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.30290191 |
| 101 | protein deneddylation (GO:0000338) | 3.30061570 |
| 102 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.29441543 |
| 103 | hydrogen transport (GO:0006818) | 3.28979304 |
| 104 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.28660777 |
| 105 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.28660777 |
| 106 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.28660777 |
| 107 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.28113891 |
| 108 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.28113891 |
| 109 | 7-methylguanosine mRNA capping (GO:0006370) | 3.27539776 |
| 110 | synaptic vesicle exocytosis (GO:0016079) | 3.25999888 |
| 111 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.22568291 |
| 112 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.19365131 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.19054265 |
| 114 | 7-methylguanosine RNA capping (GO:0009452) | 3.18738186 |
| 115 | RNA capping (GO:0036260) | 3.18738186 |
| 116 | reverse cholesterol transport (GO:0043691) | 3.16833311 |
| 117 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.16627457 |
| 118 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15689134 |
| 119 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.15590690 |
| 120 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.15590690 |
| 121 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.14870600 |
| 122 | negative regulation of protein oligomerization (GO:0032460) | 3.14239850 |
| 123 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.13841178 |
| 124 | auditory behavior (GO:0031223) | 3.12179287 |
| 125 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.11241133 |
| 126 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.07951238 |
| 127 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.07859674 |
| 128 | positive regulation of ligase activity (GO:0051351) | 3.07776137 |
| 129 | kynurenine metabolic process (GO:0070189) | 3.07251606 |
| 130 | cell communication by electrical coupling (GO:0010644) | 3.06691358 |
| 131 | response to auditory stimulus (GO:0010996) | 3.05481173 |
| 132 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.04041451 |
| 133 | mRNA catabolic process (GO:0006402) | 3.02941197 |
| 134 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.01810452 |
| 135 | tRNA processing (GO:0008033) | 3.00486824 |
| 136 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.00307776 |
| 137 | regulation of beta-amyloid formation (GO:1902003) | 2.99709616 |
| 138 | ethanol oxidation (GO:0006069) | 2.98368012 |
| 139 | dicarboxylic acid catabolic process (GO:0043649) | 2.97925745 |
| 140 | sodium ion export (GO:0071436) | 2.97913028 |
| 141 | mannosylation (GO:0097502) | 2.97153107 |
| 142 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.96758384 |
| 143 | intracellular protein transmembrane import (GO:0044743) | 2.96445298 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.95838818 |
| 145 | glial cell proliferation (GO:0014009) | 2.93512786 |
| 146 | aromatic amino acid family catabolic process (GO:0009074) | 2.93444802 |
| 147 | fructose metabolic process (GO:0006000) | 2.92367953 |
| 148 | biotin metabolic process (GO:0006768) | 2.91004872 |
| 149 | negative regulation of sodium ion transport (GO:0010766) | 2.90370576 |
| 150 | neuron cell-cell adhesion (GO:0007158) | 2.89984134 |
| 151 | cofactor catabolic process (GO:0051187) | 2.89773222 |
| 152 | bile acid biosynthetic process (GO:0006699) | 2.89339666 |
| 153 | dendritic spine morphogenesis (GO:0060997) | 2.89239620 |
| 154 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.87214104 |
| 155 | activation of protein kinase A activity (GO:0034199) | 2.87184718 |
| 156 | neurotransmitter secretion (GO:0007269) | 2.86886241 |
| 157 | cellular potassium ion homeostasis (GO:0030007) | 2.84061865 |
| 158 | cysteine metabolic process (GO:0006534) | 2.83000329 |
| 159 | amino acid import (GO:0043090) | 2.82771720 |
| 160 | cellular amino acid catabolic process (GO:0009063) | 2.81481505 |
| 161 | alpha-amino acid catabolic process (GO:1901606) | 2.80329635 |
| 162 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.76569481 |
| 163 | membrane repolarization (GO:0086009) | 2.76030640 |
| 164 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.75664981 |
| 165 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.74974106 |
| 166 | vocalization behavior (GO:0071625) | 2.71992246 |
| 167 | neuromuscular process controlling balance (GO:0050885) | 2.71805936 |
| 168 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71718288 |
| 169 | membrane repolarization during action potential (GO:0086011) | 2.70706606 |
| 170 | L-serine metabolic process (GO:0006563) | 2.70644344 |
| 171 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.70081518 |
| 172 | amino-acid betaine metabolic process (GO:0006577) | 2.67932568 |
| 173 | homocysteine metabolic process (GO:0050667) | 2.67744036 |
| 174 | negative regulation of protein localization to cell surface (GO:2000009) | 2.66670551 |
| 175 | valine metabolic process (GO:0006573) | 2.65337131 |
| 176 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.65053709 |
| 177 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.64299602 |
| 178 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.62723460 |
| 179 | proline transport (GO:0015824) | 2.62560202 |
| 180 | axonal fasciculation (GO:0007413) | 2.62286338 |
| 181 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61916316 |
| 182 | glyoxylate metabolic process (GO:0046487) | 2.61487391 |
| 183 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.61187416 |
| 184 | tryptophan catabolic process (GO:0006569) | 2.60899100 |
| 185 | indole-containing compound catabolic process (GO:0042436) | 2.60899100 |
| 186 | indolalkylamine catabolic process (GO:0046218) | 2.60899100 |
| 187 | hormone catabolic process (GO:0042447) | 2.59856574 |
| 188 | high-density lipoprotein particle remodeling (GO:0034375) | 2.55201974 |
| 189 | alanine transport (GO:0032328) | 2.55198419 |
| 190 | negative regulation of sterol transport (GO:0032372) | 2.54466903 |
| 191 | negative regulation of cholesterol transport (GO:0032375) | 2.54466903 |
| 192 | L-glutamate transport (GO:0015813) | 2.54256585 |
| 193 | acidic amino acid transport (GO:0015800) | 2.52666121 |
| 194 | negative regulation of fibrinolysis (GO:0051918) | 2.52604141 |
| 195 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.52019888 |
| 196 | layer formation in cerebral cortex (GO:0021819) | 2.51683257 |
| 197 | neuronal action potential propagation (GO:0019227) | 2.50490763 |
| 198 | serine family amino acid catabolic process (GO:0009071) | 2.49111986 |
| 199 | serine family amino acid biosynthetic process (GO:0009070) | 2.48815073 |
| 200 | cerebellar granule cell differentiation (GO:0021707) | 2.47088596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.57696917 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 5.30593504 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.15741435 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.87129151 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.81527361 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.44306386 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.03126176 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.72233430 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.61972406 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51874588 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.48224927 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.42510526 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.25214348 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.22846880 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00005793 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.94100283 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.91507059 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.87870637 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.85692640 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85053135 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.81004990 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.71192860 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.68985281 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68821714 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.67644460 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.61555222 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.54527577 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.51971522 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.50505773 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48964436 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45956201 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.44973676 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.42314436 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.37209830 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.26990643 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.25320050 |
| 37 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.25185863 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.24960710 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.22783771 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19969325 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.17965692 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16737915 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.13195015 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.12794925 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08592298 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05799448 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05001642 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01578913 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.00815083 |
| 50 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99369512 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.98703448 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98010556 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97280724 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92527235 |
| 55 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.92503275 |
| 56 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90506356 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90506356 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83146247 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81705010 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81473054 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.81333855 |
| 62 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80464574 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.79462202 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.78109734 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76598848 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76504596 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.75414787 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74086012 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.72643148 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70314420 |
| 71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68128180 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.65887891 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65540286 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63242174 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62951296 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.62906874 |
| 77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.62093337 |
| 78 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60275715 |
| 79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59845264 |
| 80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58195204 |
| 81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.58063766 |
| 82 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53439547 |
| 83 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51953093 |
| 84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48812045 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46892654 |
| 86 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45261209 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44653236 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42699455 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42147425 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40988225 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40491351 |
| 92 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39296593 |
| 93 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39237525 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.39015749 |
| 95 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38917956 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38758820 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37629208 |
| 98 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36002399 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33370549 |
| 100 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.33135658 |
| 101 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29919125 |
| 102 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29434125 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28901714 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28543011 |
| 105 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28120931 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27739327 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27632832 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27549209 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27422713 |
| 110 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26099567 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25262327 |
| 112 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22717849 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.18595146 |
| 114 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18217985 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17516431 |
| 116 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.15514746 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14873765 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14605745 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12824616 |
| 120 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12791852 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12487110 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10940020 |
| 123 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10219157 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09587523 |
| 125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08135297 |
| 126 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07373892 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06384036 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06189471 |
| 129 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05504769 |
| 130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05364748 |
| 131 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04880626 |
| 132 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.04475966 |
| 133 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.03028484 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02970694 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01463940 |
| 136 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01188016 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99941813 |
| 138 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99470355 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99238478 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98195019 |
| 141 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96395543 |
| 142 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96275723 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95782908 |
| 144 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95399885 |
| 145 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94684156 |
| 146 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94439237 |
| 147 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94192341 |
| 148 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94031656 |
| 149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92179172 |
| 150 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91911698 |
| 151 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91587358 |
| 152 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91586286 |
| 153 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.91492260 |
| 154 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.91378247 |
| 155 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90711629 |
| 156 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89400969 |
| 157 | AR_19668381_ChIP-Seq_PC3_Human | 0.88322821 |
| 158 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87194732 |
| 159 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87094528 |
| 160 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86979294 |
| 161 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86493816 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86223036 |
| 163 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84548658 |
| 164 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84019020 |
| 165 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83843934 |
| 166 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83660596 |
| 167 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.83600362 |
| 168 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83527548 |
| 169 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.83193738 |
| 170 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83162084 |
| 171 | P68_20966046_ChIP-Seq_HELA_Human | 0.82643791 |
| 172 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82053349 |
| 173 | SA1_27219007_Chip-Seq_Bcells_Human | 0.81772123 |
| 174 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81749681 |
| 175 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81411657 |
| 176 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.80553744 |
| 177 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78528668 |
| 178 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77782251 |
| 179 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.77692398 |
| 180 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.77525363 |
| 181 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74044474 |
| 182 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.73112232 |
| 183 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.72795556 |
| 184 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.72575736 |
| 185 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72435920 |
| 186 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72186863 |
| 187 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70579412 |
| 188 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.69414803 |
| 189 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.68454136 |
| 190 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68104511 |
| 191 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.67626628 |
| 192 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.67626628 |
| 193 | EWS_26573619_Chip-Seq_HEK293_Human | 0.66322431 |
| 194 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.66070475 |
| 195 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.65621159 |
| 196 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.65257124 |
| 197 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.64277544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.71594618 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.29808346 |
| 3 | MP0004858_abnormal_nervous_system | 3.87369761 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.52555417 |
| 5 | MP0005360_urolithiasis | 3.45991631 |
| 6 | MP0005365_abnormal_bile_salt | 3.42124359 |
| 7 | MP0003329_amyloid_beta_deposits | 3.35816711 |
| 8 | MP0003186_abnormal_redox_activity | 2.90656791 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.87091450 |
| 10 | MP0003011_delayed_dark_adaptation | 2.70999874 |
| 11 | MP0003786_premature_aging | 2.69722166 |
| 12 | MP0008058_abnormal_DNA_repair | 2.65109487 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.50595613 |
| 14 | MP0003718_maternal_effect | 2.48953414 |
| 15 | MP0004270_analgesia | 2.43616935 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.39973687 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.38040149 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 2.33836018 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.28424520 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.20987040 |
| 21 | MP0002938_white_spotting | 2.13996363 |
| 22 | MP0009697_abnormal_copulation | 2.13872663 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.11591740 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.04805039 |
| 25 | MP0003693_abnormal_embryo_hatching | 2.02780216 |
| 26 | MP0005083_abnormal_biliary_tract | 1.98970821 |
| 27 | MP0002064_seizures | 1.97962612 |
| 28 | MP0009745_abnormal_behavioral_response | 1.97928246 |
| 29 | MP0000516_abnormal_urinary_system | 1.96956599 |
| 30 | MP0005367_renal/urinary_system_phenotyp | 1.96956599 |
| 31 | MP0000604_amyloidosis | 1.88595770 |
| 32 | MP0008007_abnormal_cellular_replicative | 1.86334503 |
| 33 | MP0010094_abnormal_chromosome_stability | 1.86158061 |
| 34 | MP0001905_abnormal_dopamine_level | 1.85135140 |
| 35 | MP0002063_abnormal_learning/memory/cond | 1.83528006 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.82459540 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.75469685 |
| 38 | MP0001984_abnormal_olfaction | 1.74946658 |
| 39 | MP0001764_abnormal_homeostasis | 1.71569313 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.70559221 |
| 41 | MP0001486_abnormal_startle_reflex | 1.69245327 |
| 42 | MP0009046_muscle_twitch | 1.67887300 |
| 43 | MP0003690_abnormal_glial_cell | 1.64018610 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.62967925 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.62600965 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.62480454 |
| 47 | MP0001756_abnormal_urination | 1.61600649 |
| 48 | MP0002822_catalepsy | 1.59594406 |
| 49 | MP0003252_abnormal_bile_duct | 1.57938962 |
| 50 | MP0005332_abnormal_amino_acid | 1.51328483 |
| 51 | MP0003632_abnormal_nervous_system | 1.49731542 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.48960242 |
| 53 | MP0002272_abnormal_nervous_system | 1.48858366 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.48431077 |
| 55 | MP0003077_abnormal_cell_cycle | 1.47526375 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.45701368 |
| 57 | MP0004130_abnormal_muscle_cell | 1.45518789 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.43104602 |
| 59 | MP0002160_abnormal_reproductive_system | 1.42301738 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.40993844 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.37580226 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.36941868 |
| 63 | MP0009840_abnormal_foam_cell | 1.36804381 |
| 64 | MP0003075_altered_response_to | 1.34349478 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.33086105 |
| 66 | MP0002734_abnormal_mechanical_nocicepti | 1.32543544 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 1.31561414 |
| 68 | MP0003880_abnormal_central_pattern | 1.30642634 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.29958899 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.29922260 |
| 71 | MP0001853_heart_inflammation | 1.28067074 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24813090 |
| 73 | MP0004885_abnormal_endolymph | 1.22565413 |
| 74 | MP0002102_abnormal_ear_morphology | 1.20831449 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.20414548 |
| 76 | MP0003631_nervous_system_phenotype | 1.19457354 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.16925496 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.16391528 |
| 79 | MP0008877_abnormal_DNA_methylation | 1.14928156 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.14887080 |
| 81 | MP0003633_abnormal_nervous_system | 1.14479212 |
| 82 | MP0003283_abnormal_digestive_organ | 1.13839104 |
| 83 | MP0002736_abnormal_nociception_after | 1.12767604 |
| 84 | MP0005408_hypopigmentation | 1.11648895 |
| 85 | MP0002210_abnormal_sex_determination | 1.10311110 |
| 86 | MP0005410_abnormal_fertilization | 1.09033463 |
| 87 | MP0008961_abnormal_basal_metabolism | 1.07968127 |
| 88 | MP0008872_abnormal_physiological_respon | 1.07631795 |
| 89 | MP0005535_abnormal_body_temperature | 1.07468721 |
| 90 | MP0005646_abnormal_pituitary_gland | 1.06886698 |
| 91 | MP0008569_lethality_at_weaning | 1.06666270 |
| 92 | MP0009643_abnormal_urine_homeostasis | 1.05744337 |
| 93 | MP0010368_abnormal_lymphatic_system | 1.05629189 |
| 94 | MP0000955_abnormal_spinal_cord | 1.05307221 |
| 95 | MP0000751_myopathy | 1.05261556 |
| 96 | MP0000358_abnormal_cell_content/ | 1.04893265 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.04717227 |
| 98 | MP0000747_muscle_weakness | 1.03802770 |
| 99 | MP0008873_increased_physiological_sensi | 1.02979418 |
| 100 | MP0000013_abnormal_adipose_tissue | 1.02641472 |
| 101 | MP0000609_abnormal_liver_physiology | 1.02440554 |
| 102 | MP0002067_abnormal_sensory_capabilities | 1.02352575 |
| 103 | MP0003638_abnormal_response/metabolism_ | 1.01579119 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 1.01150143 |
| 105 | MP0001835_abnormal_antigen_presentation | 1.00900305 |
| 106 | MP0001968_abnormal_touch/_nociception | 1.00092946 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.98670915 |
| 108 | MP0001970_abnormal_pain_threshold | 0.98425127 |
| 109 | MP0003315_abnormal_perineum_morphology | 0.97754939 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.97340773 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.96855548 |
| 112 | MP0002090_abnormal_vision | 0.96693464 |
| 113 | MP0004147_increased_porphyrin_level | 0.95900205 |
| 114 | MP0002132_abnormal_respiratory_system | 0.95234239 |
| 115 | MP0008995_early_reproductive_senescence | 0.94184336 |
| 116 | MP0004924_abnormal_behavior | 0.93950459 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.93950459 |
| 118 | MP0005389_reproductive_system_phenotype | 0.93696426 |
| 119 | MP0003868_abnormal_feces_composition | 0.92403130 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.91223093 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.90422081 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.90363623 |
| 123 | MP0003195_calcinosis | 0.87668641 |
| 124 | MP0008874_decreased_physiological_sensi | 0.87355496 |
| 125 | MP0005423_abnormal_somatic_nervous | 0.87345405 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.87230709 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.87212140 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.85790692 |
| 129 | MP0002148_abnormal_hypersensitivity_rea | 0.84855391 |
| 130 | MP0002882_abnormal_neuron_morphology | 0.82203588 |
| 131 | MP0003634_abnormal_glial_cell | 0.82049154 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.81944438 |
| 133 | MP0004142_abnormal_muscle_tone | 0.81669834 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.80463363 |
| 135 | MP0000778_abnormal_nervous_system | 0.79983583 |
| 136 | MP0004043_abnormal_pH_regulation | 0.79093683 |
| 137 | MP0001145_abnormal_male_reproductive | 0.79013710 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.78640568 |
| 139 | MP0005330_cardiomyopathy | 0.78190645 |
| 140 | MP0005448_abnormal_energy_balance | 0.78108669 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.77955183 |
| 142 | MP0005551_abnormal_eye_electrophysiolog | 0.77713891 |
| 143 | MP0009672_abnormal_birth_weight | 0.77350868 |
| 144 | MP0002971_abnormal_brown_adipose | 0.77059379 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.76432912 |
| 146 | MP0000653_abnormal_sex_gland | 0.75952814 |
| 147 | MP0002269_muscular_atrophy | 0.75478281 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.75382945 |
| 149 | MP0002184_abnormal_innervation | 0.75289953 |
| 150 | MP0001929_abnormal_gametogenesis | 0.74972362 |
| 151 | MP0001501_abnormal_sleep_pattern | 0.72733660 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.72286948 |
| 153 | MP0002970_abnormal_white_adipose | 0.71942054 |
| 154 | MP0002332_abnormal_exercise_endurance | 0.71779061 |
| 155 | MP0001986_abnormal_taste_sensitivity | 0.71278240 |
| 156 | MP0005452_abnormal_adipose_tissue | 0.71254282 |
| 157 | MP0000538_abnormal_urinary_bladder | 0.71186505 |
| 158 | MP0004087_abnormal_muscle_fiber | 0.70849081 |
| 159 | MP0002229_neurodegeneration | 0.70490776 |
| 160 | MP0008775_abnormal_heart_ventricle | 0.70424244 |
| 161 | MP0002693_abnormal_pancreas_physiology | 0.69494455 |
| 162 | MP0001664_abnormal_digestion | 0.69367825 |
| 163 | MP0005501_abnormal_skin_physiology | 0.69086543 |
| 164 | MP0003879_abnormal_hair_cell | 0.68918185 |
| 165 | MP0001873_stomach_inflammation | 0.68511460 |
| 166 | MP0005379_endocrine/exocrine_gland_phen | 0.68386234 |
| 167 | MP0001542_abnormal_bone_strength | 0.68014517 |
| 168 | MP0000313_abnormal_cell_death | 0.67504531 |
| 169 | MP0002295_abnormal_pulmonary_circulatio | 0.66842425 |
| 170 | MP0005165_increased_susceptibility_to | 0.66784783 |
| 171 | MP0001881_abnormal_mammary_gland | 0.66399344 |
| 172 | MP0001529_abnormal_vocalization | 0.65627893 |
| 173 | MP0001879_abnormal_lymphatic_vessel | 0.65374884 |
| 174 | MP0005670_abnormal_white_adipose | 0.64945777 |
| 175 | MP0005253_abnormal_eye_physiology | 0.62747395 |
| 176 | MP0005075_abnormal_melanosome_morpholog | 0.62741909 |
| 177 | MP0002163_abnormal_gland_morphology | 0.62526320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.80648865 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.52714268 |
| 3 | Increased hepatocellular lipid droplets (HP:0006565) | 5.24225034 |
| 4 | Hepatocellular necrosis (HP:0001404) | 5.20019419 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.18313886 |
| 6 | Increased CSF lactate (HP:0002490) | 5.00517367 |
| 7 | Hepatic necrosis (HP:0002605) | 4.94879283 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 4.92874880 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.85385553 |
| 10 | Acute encephalopathy (HP:0006846) | 4.80764338 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 4.76409083 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.70185614 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.58756975 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.58756975 |
| 15 | Congenital, generalized hypertrichosis (HP:0004540) | 4.42399263 |
| 16 | Deep venous thrombosis (HP:0002625) | 4.15287313 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 3.99875532 |
| 18 | Exertional dyspnea (HP:0002875) | 3.98258919 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.92366218 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.83535346 |
| 21 | Macrocytic anemia (HP:0001972) | 3.83258971 |
| 22 | Methylmalonic acidemia (HP:0002912) | 3.81550217 |
| 23 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.73645090 |
| 24 | Myokymia (HP:0002411) | 3.66611495 |
| 25 | Xanthomatosis (HP:0000991) | 3.63682134 |
| 26 | Hyperglycinuria (HP:0003108) | 3.60756369 |
| 27 | Cerebral edema (HP:0002181) | 3.59853508 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.52429551 |
| 29 | Increased serum lactate (HP:0002151) | 3.46329130 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 3.41111983 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.33506216 |
| 32 | Postural instability (HP:0002172) | 3.30897633 |
| 33 | Hyperventilation (HP:0002883) | 3.30238919 |
| 34 | Ketoacidosis (HP:0001993) | 3.29765906 |
| 35 | Lactic acidosis (HP:0003128) | 3.29643626 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 3.27272222 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 3.17964040 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.17805795 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.17031555 |
| 40 | Hemiplegia (HP:0002301) | 3.16565805 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.16412366 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16412366 |
| 43 | Respiratory failure (HP:0002878) | 3.15570326 |
| 44 | Methylmalonic aciduria (HP:0012120) | 3.14555581 |
| 45 | Neurofibrillary tangles (HP:0002185) | 3.13270843 |
| 46 | Ketosis (HP:0001946) | 3.12890416 |
| 47 | Abnormality of renal resorption (HP:0011038) | 3.12673823 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 3.10384532 |
| 49 | Visual hallucinations (HP:0002367) | 3.09928384 |
| 50 | Increased muscle lipid content (HP:0009058) | 3.09758766 |
| 51 | Exercise intolerance (HP:0003546) | 3.04834958 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99485951 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.98112441 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.90191693 |
| 55 | Respiratory difficulties (HP:0002880) | 2.89771451 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.84282152 |
| 57 | Glycosuria (HP:0003076) | 2.84282152 |
| 58 | Hyperammonemia (HP:0001987) | 2.80136358 |
| 59 | Testicular atrophy (HP:0000029) | 2.79724838 |
| 60 | Focal motor seizures (HP:0011153) | 2.77330494 |
| 61 | Abnormal protein glycosylation (HP:0012346) | 2.75264471 |
| 62 | Abnormal glycosylation (HP:0012345) | 2.75264471 |
| 63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.75264471 |
| 64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.75264471 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.73033741 |
| 66 | Hyperalaninemia (HP:0003348) | 2.73033741 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73033741 |
| 68 | Gout (HP:0001997) | 2.72594401 |
| 69 | Hemiparesis (HP:0001269) | 2.70566732 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69279442 |
| 71 | Intention tremor (HP:0002080) | 2.68931384 |
| 72 | Aplasia involving bones of the extremities (HP:0009825) | 2.67639754 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.67639754 |
| 74 | Aplasia of the phalanges of the hand (HP:0009802) | 2.67639754 |
| 75 | Lethargy (HP:0001254) | 2.66651741 |
| 76 | Aplastic anemia (HP:0001915) | 2.63278424 |
| 77 | Delayed CNS myelination (HP:0002188) | 2.62128232 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59078586 |
| 79 | Optic disc pallor (HP:0000543) | 2.57842451 |
| 80 | Hypobetalipoproteinemia (HP:0003563) | 2.57346096 |
| 81 | Global brain atrophy (HP:0002283) | 2.56600025 |
| 82 | Leukodystrophy (HP:0002415) | 2.56532898 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 2.56346841 |
| 84 | Cholecystitis (HP:0001082) | 2.54393067 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.54393067 |
| 86 | Status epilepticus (HP:0002133) | 2.50585705 |
| 87 | Focal seizures (HP:0007359) | 2.50539427 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.49621328 |
| 89 | Myoglobinuria (HP:0002913) | 2.48207462 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47050963 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.46991985 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46991985 |
| 93 | Skin nodule (HP:0200036) | 2.45448622 |
| 94 | Action tremor (HP:0002345) | 2.45446503 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 2.44579780 |
| 96 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.43796059 |
| 97 | Pseudobulbar signs (HP:0002200) | 2.41935553 |
| 98 | Pheochromocytoma (HP:0002666) | 2.40497711 |
| 99 | Tetraplegia (HP:0002445) | 2.40182476 |
| 100 | Homocystinuria (HP:0002156) | 2.37145462 |
| 101 | Abnormality of homocysteine metabolism (HP:0010919) | 2.37145462 |
| 102 | Pallor (HP:0000980) | 2.36814249 |
| 103 | Resting tremor (HP:0002322) | 2.36721877 |
| 104 | Prolonged partial thromboplastin time (HP:0003645) | 2.33939682 |
| 105 | Horizontal nystagmus (HP:0000666) | 2.33796972 |
| 106 | Megaloblastic anemia (HP:0001889) | 2.32883765 |
| 107 | Abnormality of vitamin B metabolism (HP:0004340) | 2.32233892 |
| 108 | Impaired smooth pursuit (HP:0007772) | 2.30783833 |
| 109 | Dysmetric saccades (HP:0000641) | 2.29288176 |
| 110 | Achilles tendon contracture (HP:0001771) | 2.27172086 |
| 111 | Hyperglycinemia (HP:0002154) | 2.26780671 |
| 112 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26709782 |
| 113 | Reticulocytopenia (HP:0001896) | 2.26013368 |
| 114 | Hypothermia (HP:0002045) | 2.24998620 |
| 115 | Abnormality of placental membranes (HP:0011409) | 2.24220063 |
| 116 | Amniotic constriction ring (HP:0009775) | 2.24220063 |
| 117 | Truncal ataxia (HP:0002078) | 2.24118302 |
| 118 | Back pain (HP:0003418) | 2.24113922 |
| 119 | Epileptic encephalopathy (HP:0200134) | 2.23751244 |
| 120 | Exercise-induced myalgia (HP:0003738) | 2.22416024 |
| 121 | CNS demyelination (HP:0007305) | 2.22041549 |
| 122 | Complement deficiency (HP:0004431) | 2.22029410 |
| 123 | Depression (HP:0000716) | 2.20641984 |
| 124 | Ragged-red muscle fibers (HP:0003200) | 2.19682436 |
| 125 | Bilateral microphthalmos (HP:0007633) | 2.19633644 |
| 126 | Oral leukoplakia (HP:0002745) | 2.19333161 |
| 127 | Hyperphosphaturia (HP:0003109) | 2.18110833 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 2.17898689 |
| 129 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14245909 |
| 130 | Bradykinesia (HP:0002067) | 2.13402687 |
| 131 | Degeneration of anterior horn cells (HP:0002398) | 2.12954941 |
| 132 | Abnormality of the anterior horn cell (HP:0006802) | 2.12954941 |
| 133 | Neuroendocrine neoplasm (HP:0100634) | 2.12921398 |
| 134 | Turricephaly (HP:0000262) | 2.12812410 |
| 135 | Increased serum pyruvate (HP:0003542) | 2.11793827 |
| 136 | Hepatoblastoma (HP:0002884) | 2.11228314 |
| 137 | Renal tubular dysfunction (HP:0000124) | 2.10879872 |
| 138 | Neonatal onset (HP:0003623) | 2.10586347 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 2.09867731 |
| 140 | Hypochromic microcytic anemia (HP:0004840) | 2.08448933 |
| 141 | Epidermoid cyst (HP:0200040) | 2.07784085 |
| 142 | Abnormal eating behavior (HP:0100738) | 2.06861948 |
| 143 | Abnormality of the intrinsic pathway (HP:0010989) | 2.06849518 |
| 144 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06774318 |
| 145 | Hypoglycemic seizures (HP:0002173) | 2.06613189 |
| 146 | Abnormal social behavior (HP:0012433) | 2.05793898 |
| 147 | Impaired social interactions (HP:0000735) | 2.05793898 |
| 148 | Generalized hypotonia (HP:0001290) | 2.04419615 |
| 149 | Cholelithiasis (HP:0001081) | 2.00776073 |
| 150 | Dysmetria (HP:0001310) | 1.99007025 |
| 151 | Abnormal urine phosphate concentration (HP:0012599) | 1.98414219 |
| 152 | Distal upper limb amyotrophy (HP:0007149) | 1.97778537 |
| 153 | Upper limb amyotrophy (HP:0009129) | 1.97778537 |
| 154 | Large for gestational age (HP:0001520) | 1.97538363 |
| 155 | Hypolipoproteinemia (HP:0010981) | 1.96531244 |
| 156 | EMG: neuropathic changes (HP:0003445) | 1.95356657 |
| 157 | Spastic diplegia (HP:0001264) | 1.93516586 |
| 158 | X-linked dominant inheritance (HP:0001423) | 1.93491710 |
| 159 | Generalized myoclonic seizures (HP:0002123) | 1.92734839 |
| 160 | Metabolic acidosis (HP:0001942) | 1.91895857 |
| 161 | Opisthotonus (HP:0002179) | 1.90704603 |
| 162 | Abnormal gallbladder morphology (HP:0012437) | 1.90568060 |
| 163 | Emotional lability (HP:0000712) | 1.85837889 |
| 164 | Hypoalphalipoproteinemia (HP:0003233) | 1.85491509 |
| 165 | Sparse eyelashes (HP:0000653) | 1.85347168 |
| 166 | Cleft eyelid (HP:0000625) | 1.84946047 |
| 167 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84524766 |
| 168 | Rigidity (HP:0002063) | 1.84388273 |
| 169 | Rapidly progressive (HP:0003678) | 1.84296834 |
| 170 | Woolly hair (HP:0002224) | 1.83685311 |
| 171 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83053791 |
| 172 | Clumsiness (HP:0002312) | 1.83013429 |
| 173 | Progressive cerebellar ataxia (HP:0002073) | 1.82970746 |
| 174 | Neuronal loss in central nervous system (HP:0002529) | 1.82687266 |
| 175 | Hypopigmentation of the fundus (HP:0007894) | 1.82122663 |
| 176 | Renal cortical cysts (HP:0000803) | 1.81193762 |
| 177 | Abnormality of the periventricular white matter (HP:0002518) | 1.81107071 |
| 178 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80814621 |
| 179 | Hypoglycemic coma (HP:0001325) | 1.80753818 |
| 180 | Spastic tetraparesis (HP:0001285) | 1.79028788 |
| 181 | Molar tooth sign on MRI (HP:0002419) | 1.78211052 |
| 182 | Abnormality of midbrain morphology (HP:0002418) | 1.78211052 |
| 183 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.77947782 |
| 184 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77649974 |
| 185 | Papilledema (HP:0001085) | 1.77474091 |
| 186 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77458555 |
| 187 | Amyloidosis (HP:0011034) | 1.76491630 |
| 188 | Blindness (HP:0000618) | 1.76444320 |
| 189 | Neoplasm of the heart (HP:0100544) | 1.76229772 |
| 190 | Cerebral hypomyelination (HP:0006808) | 1.74971356 |
| 191 | Palpitations (HP:0001962) | 1.74932973 |
| 192 | Reticulocytosis (HP:0001923) | 1.73826484 |
| 193 | Pancreatic cysts (HP:0001737) | 1.72201656 |
| 194 | Abnormality of glycolysis (HP:0004366) | 1.71975330 |
| 195 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.71772130 |
| 196 | Vomiting (HP:0002013) | 1.71506988 |
| 197 | Abnormal spermatogenesis (HP:0008669) | 1.67737277 |
| 198 | Hypoplasia of the pons (HP:0012110) | 1.64330077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.64319360 |
| 2 | TLK1 | 4.39565872 |
| 3 | TRIB3 | 4.33775112 |
| 4 | STK16 | 4.22600898 |
| 5 | MST4 | 4.09875061 |
| 6 | BUB1 | 3.31187213 |
| 7 | NME1 | 2.94265110 |
| 8 | MAP3K4 | 2.86117875 |
| 9 | MAP3K12 | 2.81207558 |
| 10 | SRPK1 | 2.75443053 |
| 11 | SIK1 | 2.72724394 |
| 12 | EIF2AK1 | 2.63447362 |
| 13 | NTRK1 | 2.63094133 |
| 14 | EPHA4 | 2.59197057 |
| 15 | MAP2K4 | 2.54797388 |
| 16 | NME2 | 2.52224608 |
| 17 | MAP3K9 | 2.37821368 |
| 18 | GRK6 | 2.27359103 |
| 19 | ERN1 | 2.23051093 |
| 20 | PKN2 | 2.16241962 |
| 21 | GRK5 | 2.06887874 |
| 22 | PDK2 | 2.05147797 |
| 23 | NTRK2 | 2.00883772 |
| 24 | VRK1 | 1.98122546 |
| 25 | PHKG2 | 1.96925185 |
| 26 | PHKG1 | 1.96925185 |
| 27 | PRKD3 | 1.87395116 |
| 28 | CDK12 | 1.81872673 |
| 29 | MAP2K6 | 1.81318685 |
| 30 | NTRK3 | 1.79761188 |
| 31 | EPHA2 | 1.77440872 |
| 32 | MAP2K7 | 1.77000797 |
| 33 | MYLK | 1.73459226 |
| 34 | LMTK2 | 1.72853118 |
| 35 | TYRO3 | 1.72583305 |
| 36 | MAP3K7 | 1.66258320 |
| 37 | TESK1 | 1.64824724 |
| 38 | RIPK1 | 1.61285803 |
| 39 | KSR2 | 1.56675072 |
| 40 | NUAK1 | 1.56470438 |
| 41 | ZAK | 1.53869810 |
| 42 | TIE1 | 1.48583665 |
| 43 | MAP4K2 | 1.47347077 |
| 44 | EIF2AK3 | 1.46315037 |
| 45 | PAK6 | 1.45231541 |
| 46 | CAMKK1 | 1.42680681 |
| 47 | ICK | 1.40292946 |
| 48 | BCKDK | 1.40027545 |
| 49 | MAP3K10 | 1.37216592 |
| 50 | DMPK | 1.36410016 |
| 51 | PAK4 | 1.34530966 |
| 52 | DAPK2 | 1.29028058 |
| 53 | WNK4 | 1.26888675 |
| 54 | BMPR1B | 1.24238753 |
| 55 | MINK1 | 1.22844879 |
| 56 | INSRR | 1.22491860 |
| 57 | LIMK1 | 1.21948024 |
| 58 | ADRBK2 | 1.21531279 |
| 59 | PLK4 | 1.20390284 |
| 60 | RET | 1.18298314 |
| 61 | GRK1 | 1.17844701 |
| 62 | PDGFRA | 1.17684031 |
| 63 | PDK3 | 1.13417763 |
| 64 | PDK4 | 1.13417763 |
| 65 | TSSK6 | 1.13255767 |
| 66 | CDK8 | 1.09752503 |
| 67 | ILK | 1.09195209 |
| 68 | OXSR1 | 1.08835770 |
| 69 | PLK3 | 1.06983926 |
| 70 | WNK1 | 1.05307037 |
| 71 | TESK2 | 1.01348572 |
| 72 | KSR1 | 1.00492199 |
| 73 | STK38 | 1.00222855 |
| 74 | MAPK15 | 0.99047560 |
| 75 | SIK2 | 0.97888229 |
| 76 | DDR2 | 0.96876563 |
| 77 | ABL2 | 0.95759873 |
| 78 | PTK6 | 0.95158898 |
| 79 | CASK | 0.94685438 |
| 80 | NEK1 | 0.94577545 |
| 81 | MAP3K13 | 0.94155735 |
| 82 | TAOK1 | 0.93217701 |
| 83 | LATS2 | 0.93045940 |
| 84 | PAK3 | 0.91389707 |
| 85 | CCNB1 | 0.91192167 |
| 86 | CAMK1G | 0.90956462 |
| 87 | MARK1 | 0.87532919 |
| 88 | MARK2 | 0.86618843 |
| 89 | PLK1 | 0.84636051 |
| 90 | WNK3 | 0.83606822 |
| 91 | CDC42BPA | 0.83494682 |
| 92 | PRKCG | 0.83068739 |
| 93 | BMX | 0.82961404 |
| 94 | FLT3 | 0.82689877 |
| 95 | PIM2 | 0.82380128 |
| 96 | AURKB | 0.82200891 |
| 97 | CDK5 | 0.81684758 |
| 98 | PRKCH | 0.81166251 |
| 99 | ALK | 0.81005163 |
| 100 | MAPK7 | 0.80828450 |
| 101 | MAPKAPK3 | 0.80618382 |
| 102 | IKBKB | 0.80272289 |
| 103 | MST1R | 0.79538683 |
| 104 | PBK | 0.79421889 |
| 105 | CAMK1D | 0.74943684 |
| 106 | CAMK4 | 0.74637805 |
| 107 | CDC7 | 0.74604137 |
| 108 | PRKCI | 0.74261264 |
| 109 | ARAF | 0.73997590 |
| 110 | STK11 | 0.72001333 |
| 111 | MATK | 0.71958858 |
| 112 | RPS6KB2 | 0.71349025 |
| 113 | MAPK12 | 0.69024657 |
| 114 | CSNK1G3 | 0.68224616 |
| 115 | TAF1 | 0.67707258 |
| 116 | FRK | 0.67487952 |
| 117 | CSNK2A2 | 0.67052901 |
| 118 | BRSK1 | 0.66888997 |
| 119 | KDR | 0.65734186 |
| 120 | UHMK1 | 0.65494524 |
| 121 | CDK19 | 0.64519543 |
| 122 | EIF2AK2 | 0.64181111 |
| 123 | PDK1 | 0.62916750 |
| 124 | SGK3 | 0.62503783 |
| 125 | MAPKAPK5 | 0.61905493 |
| 126 | MAP3K6 | 0.61291674 |
| 127 | CSNK2A1 | 0.60877294 |
| 128 | CSNK1G1 | 0.60851290 |
| 129 | PASK | 0.60174146 |
| 130 | SGK494 | 0.59705165 |
| 131 | SGK223 | 0.59705165 |
| 132 | RAF1 | 0.59242156 |
| 133 | MAPK13 | 0.58904460 |
| 134 | DAPK1 | 0.58429618 |
| 135 | STK39 | 0.57478572 |
| 136 | MUSK | 0.57458023 |
| 137 | RPS6KA2 | 0.56477112 |
| 138 | FGR | 0.55692624 |
| 139 | EEF2K | 0.54691519 |
| 140 | DAPK3 | 0.54493971 |
| 141 | BMPR2 | 0.54102739 |
| 142 | CAMKK2 | 0.53043119 |
| 143 | CDK15 | 0.51774100 |
| 144 | CSF1R | 0.51686326 |
| 145 | CAMK2B | 0.50437402 |
| 146 | CAMK2G | 0.48540406 |
| 147 | CDK18 | 0.47549572 |
| 148 | PRKAA1 | 0.46322187 |
| 149 | PRKD2 | 0.46163024 |
| 150 | PDPK1 | 0.46047388 |
| 151 | MAPK4 | 0.45435799 |
| 152 | LRRK2 | 0.43993100 |
| 153 | CDK7 | 0.43610830 |
| 154 | RPS6KA3 | 0.43599122 |
| 155 | SGK2 | 0.43588647 |
| 156 | PTK2 | 0.43507527 |
| 157 | RPS6KA5 | 0.43316416 |
| 158 | PTK2B | 0.43269696 |
| 159 | CDK11A | 0.42430722 |
| 160 | CDK14 | 0.42382836 |
| 161 | TAOK3 | 0.40364637 |
| 162 | CSNK1G2 | 0.39318909 |
| 163 | PNCK | 0.38760295 |
| 164 | PRKACG | 0.38689052 |
| 165 | SGK1 | 0.38429917 |
| 166 | TRIM28 | 0.37855109 |
| 167 | ATR | 0.37773511 |
| 168 | CAMK2D | 0.37044312 |
| 169 | TTK | 0.36860942 |
| 170 | TNK2 | 0.35544840 |
| 171 | ADRBK1 | 0.34741274 |
| 172 | MET | 0.33975081 |
| 173 | TEC | 0.33567927 |
| 174 | CSNK1A1L | 0.33181689 |
| 175 | CDK3 | 0.31837022 |
| 176 | CLK1 | 0.31633059 |
| 177 | AURKA | 0.30688189 |
| 178 | MAP2K3 | 0.30345589 |
| 179 | CSNK1A1 | 0.30305006 |
| 180 | DYRK2 | 0.27196656 |
| 181 | CSNK1E | 0.26031208 |
| 182 | SCYL2 | 0.25685009 |
| 183 | STK38L | 0.25052922 |
| 184 | PRKG1 | 0.23513023 |
| 185 | FGFR1 | 0.21544812 |
| 186 | TXK | 0.21121851 |
| 187 | NEK2 | 0.20801649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.12849350 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.66327214 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.13052980 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.71903026 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59881853 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.42691677 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 3.04315731 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.61816580 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56081973 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.48850358 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.48192755 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43534344 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42405007 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36638900 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.32893506 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.31456035 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.29424277 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17055827 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.12824332 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09378066 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08837314 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.08654235 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06776054 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 2.05868704 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97225519 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94658318 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78476382 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72380953 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.71471769 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.68785431 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66981494 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.65445220 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64372524 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.62420604 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60289868 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58216520 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56205365 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54959990 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54881213 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54715147 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.54079886 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.52681454 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.51209921 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.51114701 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.49948641 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.47194650 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.45288853 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45067158 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44255821 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43394422 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40665681 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40514239 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.39400569 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33279321 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31979231 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30535465 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29841129 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27822365 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.23786579 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21471445 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21009397 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 1.19663551 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19527808 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17628382 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15752129 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13319277 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12733316 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 1.07640673 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07042926 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 1.06908464 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 1.04268186 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99177701 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96097430 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95910356 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95063054 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94209063 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92262103 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89060955 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.88503820 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88338450 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.86105238 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85141364 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84445198 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83937728 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.83933894 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82388692 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81252346 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80653325 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80281347 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79362893 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79199690 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79000456 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78040577 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.77351815 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76227863 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75075076 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74860139 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74705780 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.74112320 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71952394 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69198438 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67423915 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.66957804 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66834199 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65616844 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64888432 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64346985 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64196545 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64175883 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.62208066 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60519611 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60397403 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60337150 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59796596 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.59058480 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58486744 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57538332 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56856889 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56455374 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56114719 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56103388 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55794710 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55745613 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55575079 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54892575 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54734037 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54183997 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53831064 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53178437 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52817931 |
| 131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52625414 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50765377 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50494804 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50019049 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48803703 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48758857 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48687877 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48015650 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46921531 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.46825659 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46696146 |
| 142 | Taste transduction_Homo sapiens_hsa04742 | 0.46677203 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45534894 |
| 144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45376384 |
| 145 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44175338 |
| 146 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44068391 |
| 147 | Renin secretion_Homo sapiens_hsa04924 | 0.43035907 |
| 148 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43008291 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42749036 |
| 150 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42686596 |
| 151 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41781009 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41076531 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40438329 |
| 154 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40148233 |
| 155 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37618254 |
| 156 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37427917 |
| 157 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33300064 |
| 158 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33132116 |
| 159 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31016964 |
| 160 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29441329 |
| 161 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26904515 |
| 162 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22004894 |
| 163 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21358287 |
| 164 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.19973872 |
| 165 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19172413 |
| 166 | Cell cycle_Homo sapiens_hsa04110 | 0.17805705 |
| 167 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16964887 |
| 168 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16052269 |

